Asthma exacerbation rate reduction with benralizumab in an integrated analysis of the real-world XALOC-1 study

Category Primary study
JournalEuropean Respiratory Journal
Year 2022
This article has no abstract
Epistemonikos ID: e6c31f2625a234c0135537cc00780a5fd96a4011
First added on: Feb 15, 2025